Navigation Links
UCLA Venture Capital Fund Selects KYTHERA Biopharmaceuticals CEO Keith Leonard for First Annual Entrepreneurial Achievement Award
Date:11/12/2013

Silicon Valley, CA (PRWEB) November 12, 2013

The UCLA Venture Capital Fund announced today that Keith Leonard, president and CEO of KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH), has been presented with the 2013 UCLA Venture Capital Fund Entrepreneurial Achievement Award for his outstanding success as a UCLA-affiliated entrepreneur. The award was presented to Keith Leonard by UCLA Chancellor Gene Block and UCLA Venture Capital Fund Executive Chair Michael Silton during the Fund’s annual dinner held on November 6, 2013.

The mission of the UCLA VC Fund is to support and promote entrepreneurship at UCLA. The VC Fund mentors faculty and students, fosters the growth of UCLA companies, and connects entrepreneurs and venture capitalists with an interest in UCLA.

“UCLA is at the strongest point in its 94 year history. It is rich with intellectual prowess from its professors, possesses strong roots in entrepreneurial achievement with its alumni and greater community, and is educating the best and the brightest in its history,” said Josh Green, who received a Recognition Award for his past service as Chair of the VC Fund. “And the best part is all these forces are joining together to mentor and build a powerful entrepreneurial community committed to helping each other succeed.”

UCLA Venture Capital Fund Entrepreneurial Achievement Award
“We are so pleased to name Keith as our winner because he epitomizes what it means to be an outstanding entrepreneur and an outstanding member of the UCLA community,” said Silton. “He has successfully nurtured technology first created at Harbor-UCLA Medical Center and worked closely with the UCLA faculty in continue
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Novogen Launches Joint Venture Aimed At Developing Drugs to Fight Ovarian Cancer
2. Foundation Venture Capital Group Portfolio Company Identifies FRY Gene As Breast Cancer Susceptibility Suppressor
3. NextCODE Health Launches Operations with Exclusive License to Leverage deCODE genetics Genomics Platform for Sequence-Based Clinical Diagnostics, and $15 Million in Venture Financing
4. Benu BioVentures to Finance Early Biopharmaceutical Clinical Development
5. TesoRx and CoreRx Announce Joint Venture to Manufacture First-in-Class Oral Testosterone Drug
6. World Hematology & Flow Cytometry Market Reviewed in New Venture Planning Group DataPack Available at MarketPublishers.com
7. UM Ventures and SilcsBio, LLC Announce Licensing Agreement
8. Freeslate Collaborates with Medicines for Malaria Venture to Advance Therapeutic for Treating Malaria
9. TNI BioTech Names Terry Lierman of Summit Global Ventures as a Strategic Advisor
10. Join Cato BioVentures at BIO International Convention
11. Jerry Adams Joins VIC Technology Venture Development Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... may help in the fight against terrorism with the ... of explosives with the use of light and special ... and Actuators B: Chemical , the researchers describe a ... concentrations as low as 6.3 ppm (parts per million). ... minutes. , "Traditionally explosives detection has involved looking for ...
(Date:7/10/2014)... PNAS (Proceedings of the National Academy of Sciences) ... deprivation have a significant effect on our metabolism. The ... time of day to test for diseases such as ... , Researchers from the University of Surrey and The ... sleep deprivation, body clock disruption and metabolism, and discovered ...
(Date:7/10/2014)... observed the fractional quantum Hall effect in bilayer graphene ... be tuned by an electric field. , The ... confined to thin sheets are exposed to large magnetic ... thousands of individual electrons behave as a single system. ... well established, many details of this collective behavior remain ...
(Date:7/10/2014)... forever. Nanophysics makes sure of that. Mechanics researchers at Linkping ... Physical Review E . Knowledge that can be of ... be able to sit still forever, and walk around upside ... soon be able to buy smart new fasteners that hold ... is, sooner or later the grip is lost, no matter ...
Breaking Biology Technology:Detecting trace amounts of explosives with light 2Time of day crucial to accurately test for diseases, new research finds 2Columbia researchers observe tunable quantum behavior in bilayer graphene 2Columbia researchers observe tunable quantum behavior in bilayer graphene 3Even geckos can lose their grip 2
... 2011 Vermillion, Inc. (NASDAQ: VRML ), a ... call to give a company update following issuance of the ... Conference Call Information To access ... United States and Canada or +1 303 223-2683 internationally.  The ...
... Calif., April 19, 2011 Life Technologies ... will present at Baird,s 2011 Growth Stock Conference on ... Technologies, Chairman and Chief Executive Officer, will present on ... presentation, which will be available for three weeks following ...
... Today, H. Shep Wild, President and Chief Executive ... company focused on the research and development of ... a company overview to venture capital, pharmaceutical and ... Showcase 2011 hosted by the University of Florida ...
Cached Biology Technology:Vermillion to Host Conference Call to Present Company Update and Review Financial Results for the First Quarter 2011 2Vermillion to Host Conference Call to Present Company Update and Review Financial Results for the First Quarter 2011 3Life Technologies to Present at Baird's 2011 Growth Stock Conference 2CureFAKtor Pharmaceuticals Featured at University of Florida Innovation Showcase 2011 2CureFAKtor Pharmaceuticals Featured at University of Florida Innovation Showcase 2011 3CureFAKtor Pharmaceuticals Featured at University of Florida Innovation Showcase 2011 4
(Date:7/11/2014)... Janeiro, Brazil- In the brains of all vertebrates, ... allows an electric or chemical signal to be ... synapses, which are the most abundant type of ... formation is crucial for learning, memory, perception and ... synapses critical for brain function. For instance, ...
(Date:7/10/2014)... 2014  Pomerantz LLP has filed a class ... the "Company")(NYSE-MKT: PVCT) and certain of its officers.  ... Court, Middle District of Tennessee ... class consisting of all persons or entities who ... 17, 2013 and May 22, 2014, both dates ...
(Date:7/10/2014)... -- Unisys Corporation,s (NYSE: UIS ) subsidiary in ... that it has been selected by the Dutch Custodial Institutions ... Provision Biometrics solution for penitentiaries across The Netherlands ... a solution based on its open standards-based LEIDA ... is up to seven years, with the new system expected ...
Breaking Biology News(10 mins):Blame it on the astrocytes 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 3Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 2Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 3
... as a means to increase vegetation and preserve aesthetics ... cities, local character and biodiversity, researchers are looking to ... environments that are necessary in lightweight green roof design. ... survive in environments with little water--fit well in green ...
... fresh produce increases, vegetable and fruit producers are ... being challenged to examine traditional production practices in ... impact. A recent focus on both the positive ... across the globe working to find methods that ...
... 31 January 2014 VIB and CD3 (KU Leuven) ... agreement with AstraZeneca for the development of novel MALT1 ... The research teams of Thijs Baens and Peter ... Beyaert (VIB-UGent, Inflammation Research Center) were among the first ...
Cached Biology News:Three native aromatics indicated for use in Mediterranean extensive green roofs 2Nitrogen management studied in greenhouse pepper production 2VIB&CD3 enter into license and collaboration agreement with AstraZeneca for development of MALT1 inhibitor 2
Mouse monoclonal [PRMT5-21] to PRMT5 ( Abpromise for all tested applications). entrezGeneID: 10419 SwissProtID: O14744...
Mouse TrkC Affinity Purified Polyclonal Ab...
Mouse MMP-24 (MT5-MMP) MAb (Clone 143908)...
TMB Slow Kinetic One Component HRP Microwell Substrate, 1 L...
Biology Products: